@nabriva.com
Nabriva is a commercial-stage biopharmaceutical company engaged in the research & development of novel antibiotics to treat serious infections, with a current focus on the pleuromutilin class of antibiotics.
๐ข
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Nabriva Therapeutics is a highly respected brand committed to the research and development of new antibiotics to effectively treat infectious diseases. With a team that boasts extensive experience in both the scientific and industry sectors, Nabriva is dedicated to solving the global problem of bacterial resistance. As a commercial-stage biopharmaceutical company, Nabriva has headquarters in Ireland, alongside locations in the United States and Austria.
Their primary focus lies in delivering innovative anti-infective solutions. Lefamulin, their flagship product, is the first pleuromutilin antibiotic for both intravenous and oral administration in humans. It has successfully completed two pivotal Phase 3 trials, demonstrating its efficacy and safety in treating community-acquired bacterial pneumonia.
Additionally, Nabriva offers CONTEPOโข, a potentially groundbreaking epoxide intravenous antibiotic with a broad spectrum of activity against Gram-negative and Gram-positive bacteria. This innovative product is poised to tackle multi-drug resistant strains that pose a significant threat to hospitalized patients. Through cutting-edge research and development, Nabriva is making significant strides in the fight against infectious diseases and bacterial resistance.
Their passion for innovation and commitment to patient well-being make them a trusted and forward-thinking brand in the field of healthcare
Company Type
Public Company
Company Size
51-200
Year Founded
2006
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere ๐
All services online
Top brand categories